The phenomenon by which a subset of tumours that were initially classified as HER2-zero via CNB are reclassified as HER2-low via surgical resection samples can be attributed to limitations that are inherent to the current semiquantitative HER2 IHC scoring system. Here, ERBB2 is linked to neoplasm.